Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
CNCR Stock Price Chart Interactive Chart >
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $30.88 | 52-week high | $35.82 |
| Prev. close | $30.65 | 52-week low | $25.99 |
| Day low | $30.41 | Volume | 2,300 |
| Day high | $30.88 | Avg. volume | 6,612 |
| 50-day MA | $29.96 | Dividend yield | 0.94% |
| 200-day MA | $31.17 |
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Exchange Traded Concepts |
| Expense Ratio | 0.79% |
| Underlying Index | Loncar Cancer Immunotherapy Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 42.94M |
| Net Asset Value (NAV) | $30.67 |
| Options? | Yes |
| Total Holdings | 32 |
CNCR Top Holdings
| Symbol | Company | % of Total |
| TRIL | TRILLIUM THERAPEUTICS INC | 0.06% |
| RCUS | ARCUS BIOSCIENCES INC | 0.05% |
| ALXO | ALX ONCOLOGY HOLDINGS | 0.04% |
| REGN | Regeneron Pharmaceuticals Inc | 0.04% |
| TIL | INSTIL BIO INC | 0.04% |
| ARGX | ARGENX SE - ADR | 0.04% |
| IMAB | I-MAB-SPONSORED ADR | 0.04% |
| ATRA | ATARA BIOTHERAPEUTICS INC | 0.04% |
| MGNX | MacroGenics Inc | 0.04% |
| IOVA | Iovance Biotherapeutics Inc | 0.04% |
CNCR Price Returns
| 1-mo | 11.24% |
| 3-mo | -0.57% |
| 6-mo | 1.38% |
| 1-year | 7.17% |
| 3-year | 24.84% |
| 5-year | 21.84% |
| YTD | -2.63% |
| 2020 | 36.53% |
| 2019 | 24.22% |
| 2018 | -20.65% |
| 2017 | 13.61% |
| 2016 | -25.63% |
CNCR Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||